Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB
Mandate

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB

March 02, 2016

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB in connection with the acquistion of Lidköping Biogas AB. Lidköping Biogas produces liquid biogas for inter alia trucks and has an annual capacity of 60 GWh.

FordonsGas operates and builds gas tank stations in Sweden, and currenly operates more than 40 gas tank stations, predominantly in the western part of Sweden. Through the acquisition of Lidköping Biogas, FordonsGas Sverige will get an even better control over the production chain and can further develop sustainable mobility.

The Vinge team advising Air Liquide Advanced Business S.A./FordonsGas Sverige AB consists of Jesper Ottergren together with Anna Edström and, inter alia, Christoffer Thalin, Mathias Lindquist, Emma Hakesjö and Cecilia Cronquist.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025